Robert Wagner, associate laboratory director for the Energy Science and Technolo...
MIAMI, FLORIDA (May 23, 2024) – Coral Olazagasti expected a relatively smooth tr...
SAN FRANCISCO—May 24, 2024—In a scientific feat that broadens our knowledge of g...
MIAMI, FLORIDA (MAY 23, 2024) – The treatment landscape for multiple myeloma, th...
JST has selected winners for the third Marie Sklodowska Curie Award for young fe...
The DRIVE-RM consortium, led by Professor of Experimental Nephrology Marianne Ve...
The recently published study in the New England Journal of Medicine, as well as ...
Swedish pharma company Vicore announced the results of its phase 2a AIR trial fo...
AstraZeneca is reportedly planning to build a $1.5 billion facility in Singapore...
In a phase 2 study on idiopathic pulmonary fibrosis (IPF), Endeavor BioMedicines...
AstraZeneca has the option to acquire SixPeaks in the next two years if the latt...
Rhythm expects Imcivree will be available on the NHS in England and Wales within...
As the nitrosamine scandal continues, we explore the advancements in parenteral ...
When new medicines hit the market, sharing educational content with physicians, ...
Genmab has concluded the acquisition of ProfoundBio, a clinical-stage biotechnol...
Alvotech has entered into a collaboration with Dr. Reddy's Laboratories for the ...
